盛禾生物-B(02898)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02898 盛禾生物-B

停牌 08-07 09:20:12

6.390

+0.000

0.00%

最高6.390	最低6.390	成交量0.00
今开6.390	昨收6.390	日振幅0.00%
总市值10.03亿	流通市值10.01亿	总股本1.57亿
成交额0.00	换手率0.00%	流通股本1.57亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02898","market":"HK","secType":"STK","nameCN":"盛禾生物-B","latestPrice":6.39,"timestamp":1786065612598,"preClose":6.39,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":156666800,"shares":157000000,"eps":-0.623669,"marketStatus":"停牌","change":0,"latestTime":"08-07 09:20:12","open":6.39,"high":6.39,"low":6.39,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.59602,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786325400000},"marketStatusCode":5,"adr":0,"listingDate":1716480000000,"exchange":"SEHK","adjPreClose":6.39,"openAndCloseTimeList":[[1786066200000,1786075200000],[1786078800000,1786089600000]],"volumeRatio":0,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02898/wiki","defaultTab":"wiki","newsList":[{"id":"1156280998","title":"盛禾生物-B（02898）计划8月27日召开股东特别大会并暂停股份过户","url":"https://stock-news.laohu8.com/highlight/detail?id=1156280998","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1156280998?lang=zh_cn&edition=full","pubTime":"2026-08-07 18:00","pubTimestamp":1786096837,"startTime":"0","endTime":"0","summary":"盛禾生物-B8月7日公告称，公司董事会决定于2026年8月27日（星期四）召开股东特别大会。为厘定股东出席及投票资格，公司将自2026年8月24日（星期一）至2026年8月27日（星期四）暂停办理股份过户登记手续。公告显示，2026年8月27日为记录日期，当日在股东名册上登记的股东有权出席股东特别大会并行使投票权。公司表示，载有会议决议案详情及会议通知的股东特别大会通函将适时寄发予股东。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02898"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107837700","title":"盛禾生物-B（02898）股东要求召开股东特别大会　拟增补非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=1107837700","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107837700?lang=zh_cn&edition=full","pubTime":"2026-08-07 17:55","pubTimestamp":1786096539,"startTime":"0","endTime":"0","summary":"盛禾生物-B（02898）8月7日公告称，董事会于2026年8月6日收到两名股东——湖州市倚锋安盛创业投资合伙企业（有限合伙）与湖州市倚锋安禾创业投资合伙企业（有限合伙）的联合要求通知，提议召开股东特别大会，审议并酌情通过委任夏龙博士为非执行董事的普通决议案。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02898"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171653795","title":"盛禾生物-B 2026年7月股份变动月报表：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1171653795","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171653795?lang=zh_cn&edition=full","pubTime":"2026-08-05 17:13","pubTimestamp":1785921186,"startTime":"0","endTime":"0","summary":"盛禾生物控股有限公司于2026年8月5日向香港联合交易所有限公司提交的《股份发行人及根据〈上市规则〉第十九B章上市的香港预托证券发行人的证券变动月报表》显示，截至2026年7月31日，公司股本结构稳定，无新增发行或回购注销等变动。整体而言，截至2026年7月31日，盛禾生物控股有限公司股本总数保持不变。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02898"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656535305","title":"盛禾生物-B(02898)委聘郑郑风险管理咨询服务为独立内部监控顾问","url":"https://stock-news.laohu8.com/highlight/detail?id=2656535305","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656535305?lang=zh_cn&edition=full","pubTime":"2026-08-04 19:40","pubTimestamp":1785843605,"startTime":"0","endTime":"0","summary":"智通财经APP讯，盛禾生物-B(02898)发布公告，于2026年8月4日，基于审核委员会的推荐建议，公司委聘郑郑风险管理咨询服务有限公司为独立内部监控顾问，以进行独立内部监控检讨。独立内部监控检讨建议分为三个主要阶段进行：(i)初步评估，以了解集团现有的内部监控框架;(ii)深入检讨，以识别监控缺陷并建议补救措施;(iii)后续检讨，以评估所实行的补救措施的成效。独立内部监控检讨将涵盖集团所有关键领域的内部监控系统，包括财务汇报、采购、销售、现金管理、预付款项管理、研发、外包、合约管理、遵守上市规则，以及其他重大营运及管治流程。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475927.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02898","SFTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179726378","title":"盛禾生物-B（02898）委聘独立内控顾问并继续停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=1179726378","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179726378?lang=zh_cn&edition=full","pubTime":"2026-08-04 19:35","pubTimestamp":1785843333,"startTime":"0","endTime":"0","summary":"盛禾生物-B8月4日晚间公告，根据香港联合交易所有限公司证券上市规则第13.09条及《证券及期货条例》相关内幕消息条文，公司已委任郑郑风险管理咨询服务有限公司为独立内部监控顾问，开展独立内部监控检讨。公司表示，将适时披露检讨进展及任何重大发现。\\n\\n公司股票自2026年4月1日09:00起在联交所暂停买卖，原因系延迟刊发2025年年度业绩。停牌状态将维持至相关业绩发布完毕。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02898"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164210366","title":"盛禾生物-B（02898）公布自2026年7月22日起生效的董事会及其委员会最新架构","url":"https://stock-news.laohu8.com/highlight/detail?id=1164210366","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164210366?lang=zh_cn&edition=full","pubTime":"2026-07-22 06:05","pubTimestamp":1784671528,"startTime":"0","endTime":"0","summary":"2026年7月22日，盛禾生物-B发布董事名单与其角色及职能公告，明确自即日起公司董事会及下设三大专门委员会的最新组成情况。公告强调，上述安排自2026年7月22日起正式生效。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02898"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138855886","title":"盛禾生物-B (02898)：非执行董事范融奎任期届满将于2026年7月22日离任，股份继续停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=1138855886","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138855886?lang=zh_cn&edition=full","pubTime":"2026-07-21 23:01","pubTimestamp":1784646073,"startTime":"0","endTime":"0","summary":"盛禾生物控股有限公司7月21日公告，董事会与范融奎先生签订的董事服务合约任期将于2026年7月22日届满，届时范融奎先生将终止担任非执行董事，合约不予续签。范融奎先生确认，截至本公告日期，其与董事会及其他董事之间不存在任何意见分歧，亦无其他需提请股东及香港联合交易所有限公司关注的事宜。盛禾生物-B股份自2026年4月1日09:00起在联交所暂停买卖，并将继续暂停，直至公司刊发截至2025年12月31日止年度的年度业绩。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02898"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653206126","title":"盛禾生物-B(02898)：范融奎终止担任非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2653206126","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653206126?lang=zh_cn&edition=full","pubTime":"2026-07-21 23:01","pubTimestamp":1784646063,"startTime":"0","endTime":"0","summary":"智通财经APP讯，盛禾生物-B(02898)公布，公司与范融奎先生订立的服务合约所定的任期届满后，自2026年7月22日起，范融奎先生终止担任非执行董事。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1470616.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02898"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173332822","title":"盛禾生物-B6月股份变动月报：股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1173332822","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173332822?lang=zh_cn&edition=full","pubTime":"2026-07-06 16:47","pubTimestamp":1783327652,"startTime":"0","endTime":"0","summary":"盛禾生物控股有限公司于2026年7月6日发布2026年6月股份变动月报表。根据公告，截至2026年6月30日，该公司注册股本与已发行股份数均无变动。此外，截至6月底，盛禾生物-B已发行股份数量为156,666,800股，与上月底结余相同，未有购回、注销或库藏股变动。本次月报由公司主席兼执行董事张峰签署。盛禾生物-B确认继续遵守香港联交所《上市规则》及其他相关法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02898"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644420297","title":"盛禾生物-B(02898)：独立调查委员会委任CLA Advisory(Hong Kong)Limited为独立法证调查机构","url":"https://stock-news.laohu8.com/highlight/detail?id=2644420297","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644420297?lang=zh_cn&edition=full","pubTime":"2026-06-17 23:04","pubTimestamp":1781708652,"startTime":"0","endTime":"0","summary":"智通财经APP讯，盛禾生物-B 发布公告，于2026年6月17日，独立调查委员会委任CLA AdvisoryLimited为独立法证调查机构，以就该等事项进行独立调查。基于上述因素，独立调查委员会得出结论，认为调查机构具备独立性，并拥有进行调查所需的资历、资格、经验及资源。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1455853.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02898"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641146081","title":"盛禾生物-B(02898)委任中瑞为新任核数师","url":"https://stock-news.laohu8.com/highlight/detail?id=2641146081","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2641146081?lang=zh_cn&edition=full","pubTime":"2026-06-05 22:45","pubTimestamp":1780670727,"startTime":"0","endTime":"0","summary":"智通财经APP讯，盛禾生物-B(02898)发布公告，中汇安达已于2026年6月5日向董事会及审核委员会递交辞任函辞任现任核数师，自同日起生效。董事会经考虑审核委员会的建议后，已议决委任中瑞为新任核数师，以填补因辞任而产生的核数师职位空缺，并任职至本公司下次股东大会为止(委任核数师)。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1451040.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02898"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101628276","title":"盛禾生物-B更新5月股份变动月报，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1101628276","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101628276?lang=zh_cn&edition=full","pubTime":"2026-06-01 16:57","pubTimestamp":1780304240,"startTime":"0","endTime":"0","summary":"盛禾生物控股有限公司于2026年6月1日公布截至2026年5月31日的股份变动月报。报告显示，公司本月股本未发生新增发行、购回、注销或库藏股变动，整体股本保持稳定。本次月报披露，截至5月31日，盛禾生物控股有限公司法定/注册股本仍为200,000,000股普通股，面值每股0.0005美元，法定/注册股本合计100,000美元，较上月无变化。该公告由盛禾生物控股有限公司主席兼执行董事张峰签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02898"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638543743","title":"盛禾生物-B(02898)：成立独立调查委员会","url":"https://stock-news.laohu8.com/highlight/detail?id=2638543743","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638543743?lang=zh_cn&edition=full","pubTime":"2026-05-26 22:51","pubTimestamp":1779807095,"startTime":"0","endTime":"0","summary":"智通财经APP讯，盛禾生物-B(02898)发布公告，于2026年5月26日举行的董事会会议上，已通过董事会决议，以(i)成立独立调查委员会，就该等事项进行独立法证调查;(ii)委任陈向荣先生、冯岚女士及史录文先生为独立调查委员会的初始成员，并由陈向荣先生担任独立调查委员会主席;及(iii)授权独立调查委员会拥有一切必要权力、授权及权利以履行其职责，包括但不限于监督独立调查及相关工作、挑选合适的独立服务供应商协助进行独立调查，以及批准本公司的季度复牌进度更新公告。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446293.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02898"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159958500","title":"盛禾生物-B发布2026年4月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1159958500","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159958500?lang=zh_cn&edition=full","pubTime":"2026-05-04 16:52","pubTimestamp":1777884770,"startTime":"0","endTime":"0","summary":"盛禾生物控股有限公司于2026年5月4日发布截至2026年4月30日的股份变动月报表。本次报告期内，公司注册股本及已发行股份数未发生变化。盛禾生物控股有限公司的注册股本为200,000,000股普通股，面值为每股0.0005美元，总额为100,000美元。公司同时确认本月末仍满足香港联交所相关最低公众持股量要求。公告由公司主席兼执行董事张峰签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02898"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632602422","title":"盛禾生物-B(02898)接获联交所复牌指引 继续停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2632602422","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2632602422?lang=zh_cn&edition=full","pubTime":"2026-05-03 19:31","pubTimestamp":1777807866,"startTime":"0","endTime":"0","summary":"倘本公司情况有变，联交所可不时修订复牌指引。根据上市规则第6.01A条，倘股份已连续18个月暂停买卖，联交所可将本公司除牌。倘本公司未能于2027年9月30日前就导致其暂停买卖的事宜作出补救、履行复牌指引及全面遵守上市规则以令联交所信纳，并恢复股份买卖，则联交所上市科将建议上市委员会展开取消本公司上市地位的程序。根据上市规则第6.01及6.10条，联交所亦有权在适当情况下施加较短的特定补救期。公司股份继续停牌。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437698.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02898","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183029846","title":"盛禾生物-B更新3月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1183029846","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1183029846?lang=zh_cn&edition=full","pubTime":"2026-04-09 16:51","pubTimestamp":1775724681,"startTime":"0","endTime":"0","summary":"盛禾生物控股有限公司（盛禾生物-B）于2026年4月9日公布2026年3月股份变动月报表。本报告期自2026年3月1日至3月31日，以下为本期主要信息。\n公告显示，本月公司法定注册股本为2亿股，每股面值0.0005美元，总额维持在10万美元，与上月持平。截至本月末，公司已发行普通股数量为156,666,800股，未有新增发行、购回或注销活动，股本结构保持不变。\n公司同时确认，当前已符合适用的公众持股量要求，未出现任何违规情形。公告由主席兼执行董事张峰签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02898"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624568414","title":"盛禾生物-B(02898)4月1日起停牌 待刊发2025年全年业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2624568414","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2624568414?lang=zh_cn&edition=full","pubTime":"2026-04-01 10:18","pubTimestamp":1775009939,"startTime":"0","endTime":"0","summary":"智通财经APP讯，盛禾生物-B(02898)发布公告，公司股份将于2026年4月1日(星期三)上午九时正起在联交所暂停买卖，直至公司刊发有关2025年年度业绩的公告为止。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423751.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1161","02898"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623104355","title":"盛禾生物-B(02898)：延迟刊发2025年年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2623104355","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2623104355?lang=zh_cn&edition=full","pubTime":"2026-03-29 18:51","pubTimestamp":1774781499,"startTime":"0","endTime":"0","summary":"基于上述情况，董事会预见公司将无法按照上市规则第13.49条的规定刊发2025年年度业绩。根据上市规则第13.50条，倘发行人未能按照上市规则刊发定期财务资料，联交所通常会要求暂停买卖发行人证券，且该暂停通常将持续至发行人刊发载有所需财务资料的公告为止。据此，目前预期公司股份将于2026年4月1日上午9时正起在联交所暂停买卖，直至公司公布2025年年度业绩为止。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421371.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02898","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620440879","title":"盛禾生物-B(02898.HK)拟3月27日举行董事会会议审批年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2620440879","media":"中金财经","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2620440879?lang=zh_cn&edition=full","pubTime":"2026-03-17 17:07","pubTimestamp":1773738426,"startTime":"0","endTime":"0","summary":"格隆汇3月17日丨盛禾生物-B(02898.HK)宣布，公司将于2026年3月27日(星期五)举行董事会会议，藉以(其中包括)考虑及批准集团截至2025年12月31日止年度业绩及其刊发，考虑派发末期股息(如有)并处理任何其他事务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260317/32074864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02898","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181870903","title":"盛禾生物(02898)2月股份变动月报表：股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1181870903","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181870903?lang=zh_cn&edition=full","pubTime":"2026-03-02 17:01","pubTimestamp":1772442099,"startTime":"0","endTime":"0","summary":"盛禾生物控股有限公司（02898）于2026年3月2日披露截至2026年2月28日的股份变动月报表。公告显示，公司在报告期内注册股本维持在200,000,000股，面值为每股USD 0.0005，对应注册股本总额USD 100,000。\n公司已发行股份总数自上月底以来无新增或减少，仍为156,666,800股，未有购回或注销股份行为。公告同时显示，公司当前公众持股量符合适用的最低比例要求。\n公司于期内并无期权、可换股票据、权证或其他股份激励计划的变动。整体来看，截至2月底，盛禾生物控股有限公司无新增发行或股份变动，股本结构保持稳定。\n公告由公司主席兼执行董事张峰签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02898"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.longruntea.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0.0063},{"period":"1year","weight":-0.1235},{"period":"ytd","weight":-0.0377}],"compareEarnings":[{"period":"1week","weight":-0.0127},{"period":"1month","weight":0.0865},{"period":"3month","weight":-0.0327},{"period":"6month","weight":-0.0388},{"period":"1year","weight":0.0249},{"period":"ytd","weight":-0.0039}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"Sunho Biologics Inc是一家主要从事生物技术的研发和生产的公司。该公司主要从事发现、开发和商业化生物制剂，通过直接调节先天性和适应性免疫系统来调节免疫微环境。该公司拥有三种核心产品，即IAH0968、IAP0971及IAE0972。IAH0968是一种抗体依赖性细胞介导的细胞毒性增强型单克隆抗体，IAP0971及IAE0972均为抗体细胞因子。","yearOnYearQuotes":[{"month":1,"riseRate":0.357143,"avgChangeRate":-0.038899},{"month":2,"riseRate":0.4,"avgChangeRate":-0.004403},{"month":3,"riseRate":0.357143,"avgChangeRate":0.015388},{"month":4,"riseRate":0.333333,"avgChangeRate":0.011323},{"month":5,"riseRate":0.333333,"avgChangeRate":0.036651},{"month":6,"riseRate":0.266667,"avgChangeRate":0.072908},{"month":7,"riseRate":0.266667,"avgChangeRate":-0.002222},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.068577},{"month":9,"riseRate":0.214286,"avgChangeRate":-0.012573},{"month":10,"riseRate":0.266667,"avgChangeRate":0.020492},{"month":11,"riseRate":0.466667,"avgChangeRate":0.037807},{"month":12,"riseRate":0.4,"avgChangeRate":0.03045}],"exchange":"SEHK","name":"盛禾生物-B","nameEN":"SUNHO BIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"盛禾生物-B(02898)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供盛禾生物-B(02898)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"盛禾生物-B,02898,盛禾生物-B股票,盛禾生物-B股票老虎,盛禾生物-B股票老虎国际,盛禾生物-B行情,盛禾生物-B股票行情,盛禾生物-B股价,盛禾生物-B股市,盛禾生物-B股票价格,盛禾生物-B股票交易,盛禾生物-B股票购买,盛禾生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"盛禾生物-B(02898)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供盛禾生物-B(02898)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}